Reduce Mycotoxin Risk

Mycotoxines are secondary metabolites produced by molds that colonize agricultural commodities during pre-harvest, storage, or processing stages. These toxic compounds pose a significant threat to animal health and production performance across all livestock species. The most economically important mycotoxins in feed production include aflatoxins, zearalenone, fumonisins, deoxynivalenol (DON or vomitoxin), and ochratoxin A.

Corn and corn by-products represent the highest-risk ingredients for mycotoxin contamination, particularly aflatoxin B1 which is a potent hepatocarcinogen. Soybean meal, wheat, barley, rice, and alternative ingredients such as DDGS, sunflower meal, and cottonseed meal also frequently harbor multiple mycotoxins. The co-occurrence of several mycotoxins in a single ingredient is common and amplifies the overall toxic effect.

Climate conditions in many production regions create persistent challenges. Warm, humid environments during crop development favor Aspergillus and Fusarium mold growth. These conditions are prevalent across many areas in Africa, the Middle East, and Southeast Asia where VeritasVet serves feed producers. Climate change is expanding these risk zones, making mycotoxin management increasingly important for operations in previously lower-risk areas.

Even when contamination levels appear below regulatory thresholds, subclinical exposure causes performance losses that erode profitability. Reduced feed intake, compromised immune function, and impaired nutrient metabolism occur at mycotoxin concentrations that produce no obvious clinical signs.

Effective mycotoxin risk management requires a comprehensive testing program covering incoming raw materials, production samples, and finished feeds. Rapid testing methods including lateral flow immunochromatographic assays provide quick screening results at receiving, while more sensitive methods like ELISA or LC-MS/MS should be used for confirmation and detailed analysis.

Establishing raw material risk profiles by supplier and origin helps prioritize testing resources. Ingredients from regions with known high mycotoxin pressure warrant more frequent and comprehensive testing. Building relationships with suppliers who implement proper storage management and quality control reduces but does not eliminate risk.

For poultry operations, regular monitoring of feed and ingredients protects bird health and ensures consistent egg production or broiler growth rates. Testing should target both finished feed and individual ingredients, as blending low-level contaminated lots can produce finished feed with significant overall contamination. Working with poultry nutrition specialists helps interpret results in context of bird age and production stage.

Ruminant feeding programs present unique considerations because rumen microorganisms partially metabolize certain mycotoxins. However, high-producing dairy cows and young ruminants remain vulnerable, particularly to aflatoxin B1 which can be excreted in milk as aflatoxin M1. Ruminant operations must maintain vigilance even when rumen detoxification provides some margin of safety.

Preventing mycotoxin formation is more effective than managing contaminated ingredients after detection. Proper storage management forms the foundation of prevention, maintaining humidity below 14% for cereals and temperatures that inhibit mold growth throughout the storage period.

Storage facility design should enable adequate ventilation and permit regular inspection of ingredient quality. Bulk storage bins should have monitoring systems to detect hot spots where mold growth can initiate. First-in-first-out inventory rotation ensures older materials are used before quality deteriorates.

When purchasing ingredients, sourcing from regions with lower historical mycotoxin pressure provides some risk mitigation. However, contamination is unpredictable and cannot be guaranteed by origin alone. Establishing contractual quality specifications that include mycotoxin limits ensures supplier accountability and provides grounds for rejection if specifications are not met.

Including mold inhibitors in high-risk ingredients during storage prevents mold proliferation before processing. These products create unfavorable conditions for mold growth without affecting feed safety when used at recommended concentrations. Combining storage management with feed additives provides defense-in-depth against mycotoxin challenges.

Mycotoxin binders are functional feed additives that neutralize mycotoxins within the animal's digestive tract by adsorbing toxin molecules and preventing their absorption into the bloodstream. When included in feed formulations at appropriate concentrations, binders reduce the bioavailability of ingested mycotoxins and allow safe excretion.

Effective binders must have high adsorption capacity across the range of mycotoxins relevant to your ingredient portfolio, stability across the varying pH conditions encountered in the digestive tract, and minimal interaction with vitamins, minerals, and nutrients. ToxyFix is formulated with activated clinoptilolite and other minerals selected for broad-spectrum adsorption properties.

Different binder technologies offer varying levels of protection. Inorganic binders such as HSCAS (hydrated sodium calcium aluminosilicate) and activated clays effectively adsorb aflatoxins but may have limited efficacy against polar mycotoxins like zearalenone and DON. ToxyFix Plus combines multiple adsorption materials to extend protection across a broader range of toxins.

Binder inclusion rates should match the contamination pressure experienced. Higher contamination levels require increased inclusion rates to achieve adequate protection. Regular testing results inform binder program adjustments, with inclusion rates increased during periods of elevated risk such as immediately after harvest or when stored ingredients show any evidence of quality decline.

When mycotoxin pressure is controlled through testing, storage management, and binder inclusion, animals express their genetic potential without the drag of toxin-induced performance losses. The benefits extend across all production metrics and contribute to overall operational profitability.

Volaille operations see improvements in feed conversion efficiency, more uniform flock performance, and reduced health treatment costs when mycotoxin exposure is controlled. Layers maintain egg production and egg quality, while broilers achieve target weights more consistently with lower mortality rates.

Ruminant operations benefit from improved milk yield and composition, better reproductive performance, and stronger immune responses in both dairy and beef operations. Youngstock show improved growth rates and reduced incidence of digestive disorders that often accompany mycotoxin exposure.

Beyond direct production benefits, effective mycotoxin management protects human health by preventing carryover of aflatoxin metabolites into milk, eggs, and meat. This is particularly important for operations supplying human food chains where mycotoxin standards are enforced by regulatory agencies.

A comprehensive mycotoxin risk management strategy integrates testing protocols, storage management, and binder programs into a cohesive nutritional approach. This strategy must be flexible enough to respond to varying contamination pressure while maintaining consistent protection across all feed batches.

At VeritasVet, our technical team helps producers develop customized mycotoxin management programs based on their specific ingredient sources, production systems, and risk profiles. This includes selecting appropriate binder products, establishing testing schedules, and providing interpretation of results in the context of animal performance.

The nutritional approach to mycotoxin management recognizes that prevention and mitigation must work together. Even the best testing and storage programs cannot guarantee toxin-free ingredients under all conditions. Maintaining continuous binder protection ensures that unexpected contamination episodes do not cause acute performance losses or chronic subclinical effects.